About Macrocyclics
Macrocyclics is a company based in United States founded in 1995. Macrocyclics offers products and services including Bifunctional Chelators, Conjugates, Fluorescent Probes, cGMP Services, and Peptide Synthesis. Macrocyclics operates in a competitive market with competitors including Generate Biomedicines, Sai Life Sciences, Plexium, Acies Bio and Anagenex, among others.
- Headquarter United States
- SectorsHealthcare
- Website macrocyclics.com
- Social LinkedIn
- Legal Name Macrocyclics, Inc.
- Latest Funding Round$165.92K (USD), Grant
Jun 2014
- Investors
Products & Services of Macrocyclics
Macrocyclics offers a comprehensive portfolio of products and services, including Bifunctional Chelators, Conjugates, Fluorescent Probes, cGMP Services, and Peptide Synthesis.
Customized agents for diagnostic and therapeutic applications in medicine.
Compounds for bioconjugation in research and medical development.
Probes used for imaging and analysis in therapeutic processes.
API production for clinical trials and pharmaceutical needs.
Synthesis of peptides for medical and research applications.
Funding Insights of Macrocyclics
- Total Rounds 3
- Last Round Grant — $165,922
- First Round $165,922
(Aug 2007)
- Investors Count 1
All 3 funding rounds of Macrocyclics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Macrocyclics
Macrocyclics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Macrocyclics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Macrocyclics
2 people are tracked at Macrocyclics (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Paul Jurek | Chief Executive Officer | Leadership |
Duke Halloran | Production Manager, Business Development Lead | Team |
Complete people profiles for Macrocyclics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Macrocyclics
3 dated milestones of Macrocyclics across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Macrocyclics is founded.
- Funding First funding round of $166K.
- Funding Latest funding round, Grant, of $166K.
Competitors of Macrocyclics
Macrocyclics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Generate Biomedicines, Sai Life Sciences, Plexium, Acies Bio and Anagenex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| generatebiomedicines.com | 2018 | Somerville, United States | $643M | 286 | Developer of novel protein-based therapeutics using machine learning and biological engineering | |
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| plexium.com | 2017 | San Diego, United States | $225.12M | 81 | Integrated chemistry service provider | |
| aciesbio.com | 2006 | Ljubljana, Slovenia | – | – | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | |
| anagenex.com | 2019 | San Francisco, United States | $30M | 23 | Drug discovery services are manufactured by Anagenex in San Francisco. | |
| personalchemistry.com | 1998 | Uppsala, Sweden | $50.46M | – | Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. | |
| nfil.in | 1967 | Mumbai, India | – | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | |
| irbm.com | 2010 | Pomezia, Italy | – | – | Integrated drug discovery and preclinical development services are provided. | |
| medicilon.com | 2004 | Pudong, China | – | – | Integrated drug discovery and preclinical services are provided. |
Detailed competitors of Macrocyclics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Macrocyclics
The website of Macrocyclics (macrocyclics.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▼ 8.8% vs previous month
Websites whose visitors overlap most with Macrocyclics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
focussynthesis.com | focussynthesis.com | 100% | – | – | – |
| chemgenes.com | 100% | – | #2,747,774 | View details | |
| arkpharminc.com | 100% | – | – | View details | |
polymersource.com | polymersource.com | 100% | – | – | – |
| biopal.com | 100% | 3.5K | #5,798,977 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Macrocyclics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Macrocyclics
10 companies that operate in the same segment as Macrocyclics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Macrocyclics
Macrocyclics was founded in 1995 and raised its 1st funding round 12 years after it was founded.
Macrocyclics is headquartered in United States.
Macrocyclics was founded in 1995 in the United States and operates in the biotechnology sector, focusing on chelation chemistry. Chelating agents and related platforms are provided for diagnostic and therapeutic product development. Services include custom synthesis, peptide synthesis, bioconjugation, analytical testing such as HPLC and mass spectrometry, and consulting on chelation and bioconjugation. Products encompass bifunctional chelators, conjugates, fluorescent probes, macrocyclic ligands, and magnetic resonance reagents.
Macrocyclics's top competitors include Generate Biomedicines, Sai Life Sciences and Plexium.
Macrocyclics offers Bifunctional Chelators, Conjugates, Fluorescent Probes, cGMP Services, and Peptide Synthesis.
Macrocyclics has 1 investor. Key investors include HHS.
Macrocyclics operates through Macrocyclics, Inc..